Clinical Trial Update: An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection [Phase 2]

View source ↗

Summary

Open-label rollover Phase 2 trial of Entecavir in adults with chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Entecavir (Baraclude) (Entecavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED